CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma (Q33732597)
scientific article published on March 2, 2010
Language:
(P31) (Q13442814)
(P304) 2455-2464
(P407) (Q1860)
(P433) 6
(P478) 70
(P577) Tuesday, March 2, 2010
(P921) (Q282142)
(P953) https://cancerres.aacrjournals.org/content/canres/70/6/2455.full.pdf
http://cancerres.aacrjournals.org/cgi/content/abstract/70/6/2455
https://europepmc.org/articles/PMC2840073
https://europepmc.org/articles/PMC2840073?pdf=render
https://doi.org/10.1158/0008-5472.can-09-2505
https://aacrjournals.org/cancerres/article-pdf/70/6/2455/2649324/2455.pdf
(P1433) (Q326097)
(P1476) "CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma" (language: en)
"CD44 Attenuates Activation of the Hippo Signaling Pathway and Is a Prime Therapeutic Target for Glioblastoma" (language: en)
(P2093) Yin Xu
Ivan Stamenkovic
Qin Yu
(P2860) (Q35014308)
(Q37550974)
(Q37381798)
(Q37079980)
(Q37309171)
(Q37228574)
(Q37422836)
(Q37205122)
(Q37138979)
(Q37105079)
(Q36986304)
(Q36969009)
(Q36889961)
(Q36795086)
(Q42529926)
(Q37169157)
(Q40235602)
(Q24682018)
(Q24338599)
(Q34474913)
(Q28275474)
(Q40383820)
(Q28266862)
(Q29547317)
(Q24555728)
(Q28237942)
(Q35824079)
(Q35107972)
(Q28201701)
(Q35805198)
(Q24535043)
(Q40796680)
(Q34272357)
(Q28363493)
(Q34136635)
(Q24610450)
(Q35186457)
(Q36380973)
(Q34447308)
(Q34414797)
(Q24674652)
(Q24651739)
(Q42802879)
(Q36231630)
(Q51977217)
(Q48583425)
(Q47719947)
(Q44269066)
(Q58324027)
other details
description scientific article published on March 2, 2010

External Links